Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · IEX Real-Time Price · USD
6.68
+0.18 (2.77%)
At close: Jul 2, 2024, 4:00 PM
6.85
+0.17 (2.54%)
After-hours: Jul 2, 2024, 5:21 PM EDT

Vaccinex Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2016
Cash & Equivalents
1.546.398.5910.62.78
Upgrade
Cash & Cash Equivalents
1.546.398.5910.62.78
Upgrade
Cash Growth
-75.98%-25.59%-18.94%281.70%-85.93%
Upgrade
Receivables
0.960.1800.160.9
Upgrade
Other Current Assets
0.850.910.820.530.34
Upgrade
Total Current Assets
3.357.489.4111.294.01
Upgrade
Property, Plant & Equipment
0.280.50.440.420.59
Upgrade
Total Long-Term Assets
0.280.50.440.420.59
Upgrade
Total Assets
3.637.989.8411.74.6
Upgrade
Accounts Payable
2.041.521.063.173.21
Upgrade
Deferred Revenue
0.060000
Upgrade
Current Debt
0.220.240.228.070
Upgrade
Other Current Liabilities
3.590.780.981.943.67
Upgrade
Total Current Liabilities
5.922.542.2613.186.88
Upgrade
Long-Term Debt
0.030.250.181.130
Upgrade
Total Long-Term Liabilities
0.030.250.181.130
Upgrade
Total Liabilities
5.942.782.4314.316.88
Upgrade
Total Debt
0.250.490.399.210
Upgrade
Debt Growth
-49.07%24.36%-95.76%--
Upgrade
Retained Earnings
-339.93-319.68-299.86-277.48-248.63
Upgrade
Shareholders' Equity
-2.315.197.41-26.58-26.24
Upgrade
Net Cash / Debt
1.295.918.21.392.78
Upgrade
Net Cash / Debt Growth
-78.19%-27.97%490.71%-50.00%-85.93%
Upgrade
Net Cash Per Share
2.7829.2359.6815.5245.26
Upgrade
Working Capital
-2.574.947.15-1.89-2.87
Upgrade
Book Value Per Share
-4.9825.7053.95-297.06-427.75
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).